Genentech, Inc.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology MATTERS Rank in Class
 
 
C07K PEPTIDES 1170 1
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 1116 8
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 436 7
 
 
C07D HETEROCYCLIC COMPOUNDS 263 23
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 228 6
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 205 53
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 133 16
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 123 33
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 35 16
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 30 65
  • No Technologies to Display

Top Patents (by citation)

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0055,845 Pharmaceutical Compositions comprising Akt protein kinase inhibitors Aug 09, 17 Mar 01, 18 [A61K]
2018/0057,500 PYRAZOLE CARBOXAMIDE COMPOUNDS AND METHODS OF USE Aug 29, 17 Mar 01, 18 [C07D, A61K]
2018/0057,589 ANTI-NOTCH2 NRR ANTIBODIES Jul 21, 17 Mar 01, 18 [A61K, C07K]
2018/0057,598 MULTIVALENT AND MULTIEPITOPIC ANTIBODIES HAVING AGONISTIC ACTIVITY AND METHODS OF USE Aug 04, 17 Mar 01, 18 [A61K, C07K]
2018/0057,604 ANTI-TRANSFERRIN RECEPTOR / ANTI-BACE1 MULTISPECIFIC ANTIBODIES AND METHODS OF USE Nov 18, 15 Mar 01, 18 [G01N, C07K]
2018/0045,729 MUTANT SMOOTHENED AND METHODS OF USING THE SAME Feb 04, 16 Feb 15, 18 [C12Q, A61K, G01N, C07K]
2018/0037,661 PERTUZUMAB VARIANTS AND EVALUATION THEREOF Oct 19, 17 Feb 08, 18 [A61K, G01N, C07K]
2018/0037,662 PERTUZUMAB VARIANTS AND EVALUATION THEREOF Oct 19, 17 Feb 08, 18 [A61K, G01N, C07K]
2018/0029,984 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING Oct 03, 17 Feb 01, 18 [C07F, C07D]
2018/0021,431 METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS Jun 28, 17 Jan 25, 18 [A61K, C07K]

View all publication…

  • No Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9920120 Methods and compositions comprising purified recombinant polypeptides Mar 09, 16 Mar 20, 18 [A61K, C07K]
9920123 Anti-PD-L1 antibodies, compositions and articles of manufacture Oct 26, 16 Mar 20, 18 [A61K, C07K]
9914774 Notch pathway inhibition Jul 09, 15 Mar 13, 18 [A61K, C07K]
9908931 Anti-hemagglutinin antibodies and methods of use Feb 12, 16 Mar 06, 18 [A61K, C07K]
9895441 Methods of treating cancer using PD-L1 axis binding antagonists and VEGF antagonists Dec 01, 14 Feb 20, 18 [A61K, C07K]
9895450 Anti-wall teichoic antibodies and conjugates Nov 19, 15 Feb 20, 18 [A61K, C07K]
9896478 Antibody purification by cation exchange chromatography Nov 03, 14 Feb 20, 18 [C07K]
9896506 Anti-CD79B antibodies and immunoconjugates and methods of use Jun 09, 15 Feb 20, 18 [G01N, A61K, C07K]
9890152 Aminopyrimidine compounds as inhibitors of T790M containing EGFR mutants Jun 19, 15 Feb 13, 18 [C07D, A61K]
9884126 Anti-wall teichoic antibodies and conjugates May 22, 14 Feb 06, 18 [A61K, C07K]

View all Patent…

  • No Patents to Display

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0369,564 ANTI-VEGF ANTIBODIES Abandoned Jan 15, 16 Dec 28, 17 [C07K]
2017/0296,550 ARYL SULTAM DERIVATIVES AS RORc MODULATORS Abandoned Dec 17, 15 Oct 19, 17 [C07D, A61K]
2017/0283,505 PRODUCTION OF PROTEINS IN GLUTAMINE-FREE CELL CULTURE MEDIA Abandoned Jun 14, 17 Oct 05, 17 [C12N, C07K]
2017/0233,486 POLYNUCLEOTIDES ENCODING ANTI-NOTCH1 NRR ANTIBODY POLYPEPTIDES Abandoned Nov 22, 16 Aug 17, 17 [C07K]
2017/0234,883 ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREFOR Abandoned Jan 25, 17 Aug 17, 17 [G01N, C07K]
2017/0210,733 BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE Abandoned Apr 07, 17 Jul 27, 17 [C07D]
2017/0210,807 HUMANIZED ANTI-BETA7 ANTAGONISTS AND USES THEREFOR Abandoned Apr 11, 17 Jul 27, 17 [C07K]
2017/0196,878 USE OF CBP/EP300 AND BET INHIBITORS FOR TREATMENT OF CANCER Abandoned Mar 20, 17 Jul 13, 17 [A61K]
2017/0145,020 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS,COMPOSITIONS AND METHODS OF USE THEREOF Abandoned Feb 03, 17 May 25, 17 [C07D]
2017/0145,034 ALKYNYL ALCOHOLS AND METHODS OF USE Abandoned Feb 06, 17 May 25, 17 [C07D]
2017/0106,042 METHODS AND COMPOSITIONS FOR MODULATING HGF/MET Abandoned May 23, 16 Apr 20, 17 [G01N, A61K, C07K]
2017/0044,261 HUMANIZED ANTI-BETA7 ANTAGONISTS AND USES THEREFOR Abandoned Mar 24, 16 Feb 16, 17 [C07K]
2017/0037,147 FIXED DOSING OF HER ANTIBODIES Abandoned Oct 21, 16 Feb 09, 17 [A61K, C07K]
2017/0022,183 PROCESS FOR THE MANUFACTURING OF MEDICAMENTS Abandoned Oct 05, 16 Jan 26, 17 [C07D, C12P]
2017/0015,627 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING Abandoned Jul 28, 16 Jan 19, 17 [C07F, C07D]
2017/0001,990 PIPERIDINE-DIONE DERIVATIVES Abandoned Sep 15, 16 Jan 05, 17 [C07D]
2017/0002,017 N-SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF Abandoned Feb 05, 16 Jan 05, 17 [C07D, C07C]
2017/0000,885 METHODS OF TREATING CANCER USING ANTI-OX40 ANTIBODIES AND PD-1 AXIS BINDING ANTAGONISTS Abandoned Jun 07, 16 Jan 05, 17 [A61K]
2016/0333,011 TRIAZOLOPYRIDINE JAK INHIBITOR COMPOUNDS AND METHODS Abandoned Jul 26, 16 Nov 17, 16 [C07D]
2016/0326,142 PYRAZOLE CARBOXAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF USE Abandoned May 11, 16 Nov 10, 16 [C07D]

View all Patent…

  • No Patents to Display

Top Inventors for This Owner

We are sorry but your current selection exceeds the maximum number of watches () for this membership level. Upgrade to our Level for up to watches!

Owner Watch
Genentech, Inc.
CANCEL
UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to comparisons!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of portfolios () for this membership level. Upgrade to our Level for up to portfolios!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of patents allowed in portfolios () for this membership level. Upgrade to our Level for up to patents!

UPGRADE MEMBERSHIP CANCEL